Javier Palazuelos Selected Research

Javier Palazuelos Research Topics

3	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2018 - 04/2007
2	Demyelinating Diseases (Demyelinating Disease) 10/2021 - 01/2021
2	Neurodevelopmental Disorders 11/2018 - 10/2009
2	Huntington Disease (Huntington's Disease) 01/2011 - 11/2009
2	Multiple Sclerosis 05/2008 - 04/2007
2	Neuroinflammatory Diseases 05/2008 - 01/2008
2	Brain Injuries (Brain Injury) 08/2007 - 04/2007
1	Hypoxia (Hypoxemia) 11/2018
1	Drug Resistant Epilepsy 11/2018
1	Brain Diseases (Brain Disorder) 11/2018
1	Psychotic Disorders (Schizoaffective Disorder) 07/2013
1	Disease Progression 01/2011
1	Nerve Degeneration 11/2009
1	Schizophrenia (Dementia Praecox) 10/2009
1	Mental Disorders (Mental Disorder) 10/2009
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 05/2008
1	Stroke (Strokes) 04/2007

5	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2011 - 04/2007
3	EndocannabinoidsIBA 01/2021 - 08/2007
3	CannabinoidsIBA 11/2018 - 04/2007
2	CannabidiolIBA 11/2018 - 07/2013
1	Dronabinol (THC)FDA LinkGeneric 10/2021
1	glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA 01/2021
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2011
1	Quinolinic AcidIBA 11/2009
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 05/2008
1	CCR1 ReceptorsIBA 05/2008
1	LipidsIBA 08/2007